top of page

P02

A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection

S Donnellan(1) S Pennington(2) A Ruggiero(3) C Martinez-Rodriguez(3) M Pouget(3) J Thomas(3) S Ward(2) G Pollakis(3) G Biagini(3) W Paxton(3)

1:Edinburgh Napier University; 2:Liverpool School of Tropical Medicine; 3:The University of Liverpool

Mycobacterium tuberculosis and human immunodeficiency virus-1 (HIV-1) syndemic interactions are a major global health concern. Despite the clinical significance of coinfection, our understanding of the cellular pathophysiology and the therapeutic pharmacodynamic impact of coinfection is limited. Here, we use single-round infectious HIV-1 pseudotyped viral particles expressing green fluorescent protein alongside M. tuberculosis expressing mCherry to study pathogenesis and treatment. We report that HIV-1 infection inhibited intracellular replication of M. tuberculosis and demonstrate the therapeutic activity of antiviral treatment (efavirenz) and antimicrobial treatment (rifampicin). The described method could be applied for detailed mechanistic studies to inform the development of novel treatment strategies.

ESM Logo_White.png

Registered address:
c/o TREASURER
Matthias Merker
Parkallee 1
23845 Borstel
Germany

  • X
  • Facebook
  • LinkedIn
  • YouTube

© 2021 The European Society of Mycobacteriology

bottom of page